FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966772629> ?p ?o ?g. }

• W1966772629 endingPage "121" @default.
• W1966772629 startingPage "115" @default.
• W1966772629 abstract "Objective: To evaluate the toxicity of daily gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor, with concurrent chemoradiation (CRT) in patients with locally advanced pancreatic adenocarcinoma and prospectively evaluate plasma k-ras as a potential marker of response to gefitinib and CRT. Methods: Eleven of 12 eligible patients enrolled received a 7-day induction of gefitinib (250 mg PO) followed by daily gefitinib with concurrent CRT. Patients received 50.4 Gy/28 fractions of external beam radiation with weekly paclitaxel (40 mg/m2 IV) followed by maintenance on gefitinib. Plasma k-ras codon 12 mutations were detected using a two-stage restriction fragment length polymorphism-polymerase chain reaction assay on patients’ plasma both before and after therapy. Mutations were confirmed by direct sequencing. Results: Common adverse events included grade 1 skin rash (63%), grade 1 to 2 gastrointestinal symptoms including anorexia, nausea, vomiting, and diarrhea occurred in 63% of patients, grade 3 nausea occurred in 45% of patients. Three patients did not complete therapy, only one was possibly associated with study drug. K-ras mutations were detected in the pre-gefitinib plasma of 5/11 patients and in the matched tumor tissue of 3/4 patients. In patients where k-ras mutations were undetectable post-treatment, survival times were favorable. Conclusions: Combination of daily gefitinib with concurrent CRT in this locally advanced pancreatic cancer population was reasonably tolerated. Rapid changes in serum k-ras may provide critical information as to the efficacy of a novel agent and assist in tailoring treatment for cancers of the pancreas." @default.
• W1966772629 created "2016-06-24" @default.
• W1966772629 creator A5003463083 @default.
• W1966772629 creator A5007582269 @default.
• W1966772629 creator A5010265482 @default.
• W1966772629 creator A5013640973 @default.
• W1966772629 creator A5033103064 @default.
• W1966772629 creator A5036784999 @default.
• W1966772629 creator A5042395174 @default.
• W1966772629 creator A5052597944 @default.
• W1966772629 creator A5069558511 @default.
• W1966772629 creator A5073222544 @default.
• W1966772629 creator A5080301921 @default.
• W1966772629 date "2009-04-01" @default.
• W1966772629 modified "2023-10-05" @default.
• W1966772629 title "Results of a Phase I Trial of 12 Patients With Locally Advanced Pancreatic Carcinoma Combining Gefitinib, Paclitaxel, and 3-Dimensional Conformal Radiation" @default.
• W1966772629 cites W1931508686 @default.
• W1966772629 cites W1973938118 @default.
• W1966772629 cites W1977072117 @default.
• W1966772629 cites W1992238664 @default.
• W1966772629 cites W1998036846 @default.
• W1966772629 cites W2000484387 @default.
• W1966772629 cites W2002734622 @default.
• W1966772629 cites W2008803651 @default.
• W1966772629 cites W2012882585 @default.
• W1966772629 cites W2016044915 @default.
• W1966772629 cites W2016236483 @default.
• W1966772629 cites W2021568975 @default.
• W1966772629 cites W2025313715 @default.
• W1966772629 cites W2047318784 @default.
• W1966772629 cites W2054047807 @default.
• W1966772629 cites W2059780149 @default.
• W1966772629 cites W2061142163 @default.
• W1966772629 cites W2073768319 @default.
• W1966772629 cites W2082601343 @default.
• W1966772629 cites W2083733546 @default.
• W1966772629 cites W2093488145 @default.
• W1966772629 cites W2094040904 @default.
• W1966772629 cites W2095036127 @default.
• W1966772629 cites W2097191207 @default.
• W1966772629 cites W2106888561 @default.
• W1966772629 cites W2115812130 @default.
• W1966772629 cites W2118575220 @default.
• W1966772629 cites W2120718661 @default.
• W1966772629 cites W2123027432 @default.
• W1966772629 cites W2125547473 @default.
• W1966772629 cites W2150698989 @default.
• W1966772629 cites W2150881991 @default.
• W1966772629 cites W2158134441 @default.
• W1966772629 cites W2164034599 @default.
• W1966772629 cites W4253769310 @default.
• W1966772629 doi "https://doi.org/10.1097/coc.0b013e318180baa3" @default.
• W1966772629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19307945" @default.
• W1966772629 hasPublicationYear "2009" @default.
• W1966772629 type Work @default.
• W1966772629 sameAs 1966772629 @default.
• W1966772629 citedByCount "20" @default.
• W1966772629 countsByYear W19667726292012 @default.
• W1966772629 countsByYear W19667726292013 @default.
• W1966772629 countsByYear W19667726292014 @default.
• W1966772629 countsByYear W19667726292016 @default.
• W1966772629 countsByYear W19667726292017 @default.
• W1966772629 countsByYear W19667726292022 @default.
• W1966772629 crossrefType "journal-article" @default.
• W1966772629 hasAuthorship W1966772629A5003463083 @default.
• W1966772629 hasAuthorship W1966772629A5007582269 @default.
• W1966772629 hasAuthorship W1966772629A5010265482 @default.
• W1966772629 hasAuthorship W1966772629A5013640973 @default.
• W1966772629 hasAuthorship W1966772629A5033103064 @default.
• W1966772629 hasAuthorship W1966772629A5036784999 @default.
• W1966772629 hasAuthorship W1966772629A5042395174 @default.
• W1966772629 hasAuthorship W1966772629A5052597944 @default.
• W1966772629 hasAuthorship W1966772629A5069558511 @default.
• W1966772629 hasAuthorship W1966772629A5073222544 @default.
• W1966772629 hasAuthorship W1966772629A5080301921 @default.
• W1966772629 hasConcept C121608353 @default.
• W1966772629 hasConcept C126322002 @default.
• W1966772629 hasConcept C143998085 @default.
• W1966772629 hasConcept C2776694085 @default.
• W1966772629 hasConcept C2778496288 @default.
• W1966772629 hasConcept C2778570526 @default.
• W1966772629 hasConcept C2779438470 @default.
• W1966772629 hasConcept C2780210213 @default.
• W1966772629 hasConcept C2780580376 @default.
• W1966772629 hasConcept C2780580887 @default.
• W1966772629 hasConcept C2780852908 @default.
• W1966772629 hasConcept C2908647359 @default.
• W1966772629 hasConcept C31760486 @default.
• W1966772629 hasConcept C509974204 @default.
• W1966772629 hasConcept C71924100 @default.
• W1966772629 hasConcept C90924648 @default.
• W1966772629 hasConcept C99454951 @default.
• W1966772629 hasConceptScore W1966772629C121608353 @default.
• W1966772629 hasConceptScore W1966772629C126322002 @default.
• W1966772629 hasConceptScore W1966772629C143998085 @default.
• W1966772629 hasConceptScore W1966772629C2776694085 @default.
• W1966772629 hasConceptScore W1966772629C2778496288 @default.
• W1966772629 hasConceptScore W1966772629C2778570526 @default.

• next